Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice

被引:38
|
作者
Zhang, Mengling [1 ,2 ,3 ]
Sun, Jin [1 ]
Li, Min [1 ]
Jin, Xia [3 ]
机构
[1] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
[3] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China
基金
美国国家科学基金会; 国家重点研发计划;
关键词
TETRAVALENT DENGUE VACCINE; NONSTRUCTURAL PROTEIN NS1; DNA VACCINE; VIRUS; EFFICACY; IMMUNITY; ENHANCEMENT; ANTIBODIES; INFLUENZA; RESPONSES;
D O I
10.1016/j.omtm.2020.07.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dengue virus (DENV) infection is a major global public health concern, and there is no effective vaccine for it. In this study, we describe the design and characterization of three nucleotide-modified mRNA vaccines (prME-mRNA, E80-mRNA, and NS1-mRNA) for DENV-2. Our results showed that vaccination with E80-mRNA alone or a combination of E80-mRNA and NS1-mRNA can induce high levels of neutralizing antibodies and antigen-specific T cell responses; furthermore, these vaccines confer complete protection against DENV-2 challenge in immunocompetent mice. These data provide foundations for further development of a tetravalent DENV vaccine based on nucleotide-modified mRNA.
引用
收藏
页码:702 / 712
页数:11
相关论文
共 50 条
  • [41] DEGREE OF PROTECTION GIVEN BY LIVING VACCINES AGAINST EXPERIMENTAL INFECTION WITH BRUCELLA MELITENSIS IN GOATS
    BRINLEY, WJ
    LITTLEJO.AI
    MACKINNO.DJ
    LAWSON, JR
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1966, 34 (01) : 33 - &
  • [42] Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
    Ying, Baoling
    Scheaffer, Suzanne M.
    Whitener, Bradley
    Liang, Chieh-Yu
    Dmytrenko, Oleksandr
    Mackin, Samantha
    Wu, Kai
    Lee, Diana
    Avena, Laura E.
    Chong, Zhenlu
    Case, James Brett
    Ma, LingZhi
    Kim, Thu T. M.
    Sein, Caralyn E.
    Woods, Angela
    Berrueta, Daniela Montes
    Chang, Gwo-Yu
    Stewart-Jones, Guillaume
    Renzi, Isabella
    Lai, Yen-Ting
    Malinowski, Agata
    Carfi, Andrea
    Elbashir, Sayda M.
    Edwards, Darin K.
    Thackray, Larissa B.
    Diamond, Michael S.
    CELL, 2022, 185 (09) : 1572 - +
  • [43] Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice
    Shaikh, Mohammad Omar Faruk
    Schaefers, Matthew M.
    Merakou, Christina
    DiBlasi, Marco
    Bonney, Sarah
    Liao, Tiffany
    Zurakowski, David
    Kehl, Margaret
    Tabor, David E.
    DiGiandomenico, Antonio
    Priebe, Gregory P.
    INFECTION AND IMMUNITY, 2022, 90 (10)
  • [44] Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
    Wu, Kai
    Choi, Angela
    Koch, Matthew
    Elbashir, Sayda
    Ma, LingZhi
    Lee, Diana
    Woods, Angela
    Henry, Carole
    Palandjian, Charis
    Hill, Anna
    Jani, Hardik
    Quinones, Julian
    Nunna, Naveen
    O'Connell, Sarah
    McDermott, Adrian B.
    Falcone, Samantha
    Narayanan, Elisabeth
    Colpitts, Tonya
    Bennett, Hamilton
    Corbett, Kizzmekia S.
    Seder, Robert
    Graham, Barney S.
    Stewart-Jones, Guillaume B. E.
    Carfi, Andrea
    Edwards, Darin K.
    VACCINE, 2021, 39 (51) : 7394 - 7400
  • [45] Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice
    Zhou, Jinge
    Ye, Tianxi
    Yang, Yun
    Li, Entao
    Zhang, Kaiyue
    Wang, Yuping
    Chen, Shaohong
    Hu, Jiang
    Zhang, Kai
    Liu, Fang
    Gong, Rui
    Chuai, Xia
    Wang, Zefeng
    Chiu, Sandra
    MOLECULAR THERAPY, 2024, 32 (06) : 1779 - 1789
  • [46] Adjuvanted vaccines driven protection against visceral infection in BALB/c mice by Leishmania donovani
    Goyal, Deepak Kumar
    Keshav, Poonam
    Kaur, Sukhbir
    MICROBIAL PATHOGENESIS, 2021, 151
  • [47] Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
    Magini, Diletta
    Giovani, Cinzia
    Mangiavacchi, Simona
    Maccari, Silvia
    Cecchi, Raffaella
    Ulmer, Jeffrey B.
    De Gregorio, Ennio
    Geall, Andrew J.
    Brazzoli, Michela
    Bertholet, Sylvie
    PLOS ONE, 2016, 11 (08):
  • [48] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Yuehong Hu
    Qiu Sun
    Signal Transduction and Targeted Therapy, 7
  • [49] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Hu, Yuehong
    Sun, Qiu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [50] Modified mRNA Vaccines Protect against Zika Virus Infection (vol 168, pg 1114, 2017)
    Richner, Justin M.
    Himansu, Sunny
    Dowd, Kimberly A.
    Butler, Scott L.
    Salazar, Vanessa
    Fox, Julie M.
    Julander, Justin G.
    Tang, William W.
    Shresta, Sujan
    Pierson, Theodore C.
    Ciaramella, Giuseppe
    Diamond, Michael S.
    CELL, 2017, 169 (01) : 176 - 176